Expression Profile of Osteoclasts Following the Stimulation With Interleukin-23 in Mice

Overview

Journal Arch Rheumatol

Specialty Rheumatology

Date 2021 Mar 24

PMID 33758810

Citations 2

Authors

Miao Chen

Dan-Dan Pang

Sheng-Ming Dai

Affiliations

Soon will be listed here.

Abstract

Objectives: This study aims to analyze the expression profile of osteoclasts (OCs) following the stimulation with interleukin 23 (IL-23) in mice, which would imply the underlying effects of IL-23 on the function of OCs in inflammatory arthritis.

Materials And Methods: Mature OCs were induced from bone marrow mononuclear cells of 5 male mice (age 6 weeks; weighing 18-20 g) in the presence of macrophage-colony stimulating factor (50 ng/mL) and receptor activator of nuclear factor kappa B ligand (30 ng/mL) in vitro. The Agilent SurePrint G3 Mouse GE V2.0 Microarray was used to analyze the gene expression profile of OCs stimulated with IL-23 (30 ng/mL) or vehicle. The four major IL-23-modulated genes were validated by quantitative real-time polymerase chain reaction (qPCR) analysis.

Results: The expression levels of 23 genes were up-regulated and 32 genes were down-regulated by IL-23 stimulation (fold change ≥1.5 and p value <0.05). Among them, there were 37 genes with assigned gene symbols. Gene ontology analysis showed that the IL-23-regulated messenger ribonucleic acids (mRNAs) were related to positive regulation of leukocyte chemotaxis, chemokine-mediated signaling pathway and C-X-C chemokine receptors binding. The pathway analysis showed that the IL-23-regulated mRNAs were related to chemokine signaling pathway and cytokine-cytokine receptor interaction. The significant up-regulation of chemokine (C-X-C motif) ligand 1 and chemokine (C-X-C motif) ligand 2 induced by IL-23 was confirmed by qPCR. In addition, there were 18 long non-coding RNAs that were regulated by IL-23, while their function needs to be confirmed in the future.

Conclusion: Expression levels of genes related to chemotaxis in OCs were up-regulated by IL-23 in mice, which imply that IL-23 may facilitate chemotaxis of OCs in inflammatory arthritis.

Citing Articles

Osteoarthritis versus psoriasis arthritis: Physiopathology, cellular signaling, and therapeutic strategies.

Juma S, Liao J, Huang Y, Vlashi R, Wang Q, Wu B Genes Dis. 2024; 11(3):100986.

PMID: 38292181 PMC: 10825447. DOI: 10.1016/j.gendis.2023.04.021.

Terminally differentiated osteoclasts organize centrosomes into large clusters for microtubule nucleation and bone resorption.

Philip R, Fiorino C, Harrison R Mol Biol Cell. 2022; 33(8):ar68.

PMID: 35511803 PMC: 9635281. DOI: 10.1091/mbc.E22-03-0098.

References

Chang J, Voorhees T, Liu Y, Zhao Y, Chang C . Interleukin-23 production in dendritic cells is negatively regulated by protein phosphatase 2A. Proc Natl Acad Sci U S A. 2010; 107(18):8340-5. PMC: 2889593. DOI: 10.1073/pnas.0914703107. View

Kang K, Nam S, Kim B, Lim J, Yang Y, Lee M . Inhibition of osteoclast differentiation by overexpression of NDRG2 in monocytes. Biochem Biophys Res Commun. 2015; 468(4):611-6. DOI: 10.1016/j.bbrc.2015.10.167. View

Burmester G, Feist E, Dorner T . Emerging cell and cytokine targets in rheumatoid arthritis. Nat Rev Rheumatol. 2013; 10(2):77-88. DOI: 10.1038/nrrheum.2013.168. View

Tanaka S, Takahashi N, Udagawa N, Tamura T, Akatsu T, Stanley E . Macrophage colony-stimulating factor is indispensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest. 1993; 91(1):257-63. PMC: 330022. DOI: 10.1172/JCI116179. View

Semple B, Kossmann T, Morganti-Kossmann M . Role of chemokines in CNS health and pathology: a focus on the CCL2/CCR2 and CXCL8/CXCR2 networks. J Cereb Blood Flow Metab. 2009; 30(3):459-73. PMC: 2949152. DOI: 10.1038/jcbfm.2009.240. View

Rueda B, Orozco G, Raya E, Fernandez-Sueiro J, Mulero J, Blanco F . The IL23R Arg381Gln non-synonymous polymorphism confers susceptibility to ankylosing spondylitis. Ann Rheum Dis. 2008; 67(10):1451-4. DOI: 10.1136/ard.2007.080283. View

Abu Al Fadl E, Fattouh M, Allam A . High IL-23 level is a marker of disease activity in rheumatoid arthritis. Egypt J Immunol. 2014; 20(2):85-92. View

Shin H, Sarin R, Dixit N, Wu J, Gershwin E, Bowman E . Crosstalk among IL-23 and DNAX activating protein of 12 kDa-dependent pathways promotes osteoclastogenesis. J Immunol. 2014; 194(1):316-24. PMC: 4272876. DOI: 10.4049/jimmunol.1401013. View

Hardaway A, Herroon M, Rajagurubandara E, Podgorski I . Marrow adipocyte-derived CXCL1 and CXCL2 contribute to osteolysis in metastatic prostate cancer. Clin Exp Metastasis. 2015; 32(4):353-68. PMC: 4393805. DOI: 10.1007/s10585-015-9714-5. View

10.

Deng Y, Yao L, Chau L, Ng S, Peng Y, Liu X . N-Myc downstream-regulated gene 2 (NDRG2) inhibits glioblastoma cell proliferation. Int J Cancer. 2003; 106(3):342-7. DOI: 10.1002/ijc.11228. View

11.

Filer C, Ho P, Smith R, Griffiths C, Young H, Worthington J . Investigation of association of the IL12B and IL23R genes with psoriatic arthritis. Arthritis Rheum. 2008; 58(12):3705-9. PMC: 3001112. DOI: 10.1002/art.24128. View

12.

Valerio M, Herbert B, Basilakos D, Browne C, Yu H, Kirkwood K . Critical role of MKP-1 in lipopolysaccharide-induced osteoclast formation through CXCL1 and CXCL2. Cytokine. 2014; 71(1):71-80. PMC: 4254057. DOI: 10.1016/j.cyto.2014.08.007. View

13.

Guo Y, Wang N, Zhao S, Hou L, Xu Y, Zhang N . Increased interleukin-23 is associated with increased disease activity in patients with rheumatoid arthritis. Chin Med J (Engl). 2013; 126(5):850-4. View

14.

Razawy W, van Driel M, Lubberts E . The role of IL-23 receptor signaling in inflammation-mediated erosive autoimmune arthritis and bone remodeling. Eur J Immunol. 2017; 48(2):220-229. PMC: 5838536. DOI: 10.1002/eji.201646787. View

15.

Chen L, Wei X, Evans B, Jiang W, Aeschlimann D . IL-23 promotes osteoclast formation by up-regulation of receptor activator of NF-kappaB (RANK) expression in myeloid precursor cells. Eur J Immunol. 2008; 38(10):2845-54. DOI: 10.1002/eji.200838192. View

16.

Gaffen S, Jain R, Garg A, Cua D . The IL-23-IL-17 immune axis: from mechanisms to therapeutic testing. Nat Rev Immunol. 2014; 14(9):585-600. PMC: 4281037. DOI: 10.1038/nri3707. View

17.

Sato K, Suematsu A, Okamoto K, Yamaguchi A, Morishita Y, Kadono Y . Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction. J Exp Med. 2006; 203(12):2673-82. PMC: 2118166. DOI: 10.1084/jem.20061775. View

18.

Nakagawa N, Kinosaki M, Yamaguchi K, Shima N, Yasuda H, Yano K . RANK is the essential signaling receptor for osteoclast differentiation factor in osteoclastogenesis. Biochem Biophys Res Commun. 1999; 253(2):395-400. DOI: 10.1006/bbrc.1998.9788. View

19.

Bowes J, Orozco G, Flynn E, Ho P, Brier R, Marzo-Ortega H . Confirmation of TNIP1 and IL23A as susceptibility loci for psoriatic arthritis. Ann Rheum Dis. 2011; 70(9):1641-4. PMC: 3147229. DOI: 10.1136/ard.2011.150102. View

20.

Niu N, Xiang J, Yang Q, Wang L, Wei Z, Chen L . RNA-binding protein SAMD4 regulates skeleton development through translational inhibition of Mig6 expression. Cell Discov. 2017; 3:16050. PMC: 5259697. DOI: 10.1038/celldisc.2016.50. View